Key Stats for CEG Stock
- Past week performance: -4.4%
- 52-week range: $229 to $413
- Valuation model target price: $295
- Implied upside: 3.1% over 2.3 years
Examine why Constellation’s nuclear contracting pace hasn’t shown up in its valuation yet (It’s free) >>>
Buying and Selling Power Plants at the Same Time
Constellation Energy (CEG) has spent the past six weeks doing two things that seem contradictory. It’s been buying power plants and selling them, sometimes in the same month. On September 10, Constellation agreed to acquire Shell’s 609 MW Rhode Island State Energy Center for $715 million. Management expects the deal to be immediately accretive with returns above its 10% unlevered hurdle.
That follows an August agreement to sell the 606 MW Brazos Valley gas plant to LS Power for $860 million, a divestiture tied to the Calpine acquisition.
The strategy becomes clearer once you look at nuclear. Constellation signed 920 MW of new long term nuclear power purchase agreements in Q2, with contract durations averaging 18.5 years. CEO Joe Dominguez summed up the quarter simply. He called it “strong results, an increase in guidance, positive regulatory developments, good progress on strategic transactions.”
That confidence showed up in the numbers too. Q2 adjusted operating EPS came in at $2.55, up $0.64 year over year. Management responded by raising full year guidance to $11.50 to $12.50 per share, up from $11.00 to $12.00. Going forward, the pattern looks deliberate. Constellation is trading gas assets it doesn’t need for nuclear power it can sell at a premium to data center customers.
Track how Constellation’s nuclear PPA signings compare to its 2026 guidance range (It’s free) >>>
Is Constellation Energy Stock Still Cheap After Its Rally?
Under valuation model assumptions realized through 12/31/28, the stock is modeled using:
- Revenue Growth (CAGR): 14.4%
- Operating Margins: 12.1%
- Exit P/E Multiple: 23.2x
Based on these inputs, the model estimates a target price of $295, implying 3.1% total upside and a 1.3% annualized return over the next 2.3 years.
A 3.1% total return forecast is a notably modest number. That’s true for a stock that’s been central to the nuclear power narrative all year. After running from roughly $120 to a 52-week high near $413, Constellation’s valuation has largely caught up to its near term earnings growth.
Revenue growth of 14.4% looks strong on paper, driven by Calpine integration and new nuclear contracts layering onto the base business. But a 23.2x exit multiple already prices in a lot of that optimism. For the stock to deliver more upside, growth assumptions need to prove conservative.
Margins send a mixed signal here. A 12.1% operating margin sits below Exelon’s forecast in this same group of names. That reflects Constellation’s exposure to commodity power prices and generation costs, a trade off for owning the nuclear fleet directly.
The muted near term return doesn’t mean the long term nuclear story is wrong. It means the easy money from the initial re-rating may already sit behind the stock.
How Constellation Compares to Other Power Producers
Constellation’s most direct comparisons are Exelon (EXC), its former corporate sibling that retains the regulated transmission business, and Vistra Corp (VST), another major independent power producer with growing nuclear exposure.
On growth, Constellation’s 14.4% forecasted revenue CAGR far outpaces Exelon’s 4.1%. That gap reflects the difference between a merchant generator capturing rising power prices and a regulated utility earning fixed, rate approved returns. This growth gap is the core reason Constellation trades at a richer 23.2x multiple versus Exelon’s 14.7x.
On margins, the comparison flips completely. Exelon’s regulated model produces steadier, higher margins near 23.6%, while Constellation’s 12.1% reflects fuel costs, refueling outage timing, and commodity swings.
Against Vistra, which has also signed large data center deals, Constellation carries more leverage following the Calpine acquisition, with net debt to EBITDA near 3.0x. That’s worth watching, since it limits how much additional M&A firepower Constellation has left.
What’s Driving CEG Stock Going Forward?
The Crane Clean Energy Center restart offers the clearest near term catalyst. Dominguez has emphasized community relationships as central to winning public support, and progress there would add new baseload supply under long term contracts.
Portfolio optimization remains an active lever too. With the Rhode Island acquisition and Brazos Valley divestiture both pending approval, expected to close in Q1 2027, Constellation continues trading lower margin gas assets for nuclear adjacent capacity.
Regulatory tailwinds are building at the federal level. Management noted that FERC and PJM are establishing faster pathways for connecting large loads to the grid, which has already helped Constellation sign nearly a gigawatt of new agreements.
Capital returns round out the picture. Constellation reiterated plans to execute up to $5 billion in share repurchases by the end of 2027, giving management a lever to support per share earnings growth.
Should You Invest in Constellation Energy?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up CEG, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track CEG alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze CEG stock on TIKR Free→
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
